These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24026672)

  • 1. Generation of a replication-competent simian-human immunodeficiency virus, the neutralization sensitivity of which can be enhanced in the presence of a small-molecule CD4 mimic.
    Otsuki H; Hishiki T; Miura T; Hashimoto C; Narumi T; Tamamura H; Yoshimura K; Matsushita S; Igarashi T
    J Gen Virol; 2013 Dec; 94(Pt 12):2710-2716. PubMed ID: 24026672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2).
    Cayabyab M; Karlsson GB; Etemad-Moghadam BA; Hofmann W; Steenbeke T; Halloran M; Fanton JW; Axthelm MK; Letvin NL; Sodroski JG
    J Virol; 1999 Feb; 73(2):976-84. PubMed ID: 9882298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus.
    Himeno A; Ishida Y; Mori H; Matsuura K; Kikukawa M; Sakawaki H; Miura T
    Arch Virol; 2019 May; 164(5):1297-1308. PubMed ID: 30820667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response.
    Laird ME; Igarashi T; Martin MA; Desrosiers RC
    J Virol; 2008 Nov; 82(22):11054-65. PubMed ID: 18768967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
    Ndung'u T; Lu Y; Renjifo B; Touzjian N; Kushner N; Pena-Cruz V; Novitsky VA; Lee TH; Essex M
    J Virol; 2001 Dec; 75(23):11417-25. PubMed ID: 11689623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a replication-competent chimeric simian-human immunodeficiency virus carrying env from subtype C clinical isolate through intracellular homologous recombination.
    Fujita Y; Otsuki H; Watanabe Y; Yasui M; Kobayashi T; Miura T; Igarashi T
    Virology; 2013 Feb; 436(1):100-11. PubMed ID: 23219366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env.
    Huang L; Kusagawa S; Zeng H; Yang G; Sun B; Miura T; Yang R
    J Med Primatol; 2014 Feb; 43(1):11-21. PubMed ID: 24020838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
    Klinger JM; Himathongkham S; Legg H; Luciw PA; Barnett SW
    AIDS; 1998 May; 12(8):849-57. PubMed ID: 9631137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.
    Letvin NL; Robinson S; Rohne D; Axthelm MK; Fanton JW; Bilska M; Palker TJ; Liao HX; Haynes BF; Montefiori DC
    J Virol; 2001 May; 75(9):4165-75. PubMed ID: 11287566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
    Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a new simian/human immunodeficiency viruses clone carrying an env gene derived from a CRF07_BC strain.
    Li Y; Yang GB; Chen QM; Liu Q; Meng ZF; Geng YQ; Qiao WT; Shao YM
    Chin Med J (Engl); 2009 Dec; 122(23):2874-9. PubMed ID: 20092794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.
    Swanstrom AE; Haggarty B; Jordan APO; Romano J; Leslie GJ; Aye PP; Marx PA; Lackner AA; Del Prete GQ; Robinson JE; Betts MR; Montefiori DC; LaBranche CC; Hoxie JA
    J Virol; 2016 May; 90(10):4966-4980. PubMed ID: 26937037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
    Liao HX; Etemad-Moghadam B; Montefiori DC; Sun Y; Sodroski J; Scearce RM; Doms RW; Thomasch JR; Robinson S; Letvin NL; Haynes BF
    J Virol; 2000 Jan; 74(1):254-63. PubMed ID: 10590113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
    Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
    J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of primary isolate-like variants of simian-human immunodeficiency virus.
    Crawford JM; Earl PL; Moss B; Reimann KA; Wyand MS; Manson KH; Bilska M; Zhou JT; Pauza CD; Parren PW; Burton DR; Sodroski JG; Letvin NL; Montefiori DC
    J Virol; 1999 Dec; 73(12):10199-207. PubMed ID: 10559336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.